Gilead Sciences' top products based on revenue 2021-2023
This statistic shows the top products of biopharmaceutical company Gilead Sciences from 2021 to 2023, based on revenue. Gilead Sciences Inc. is headquartered in California and is specialized in discovering, developing and commercializing therapeutics. In 2023, Gilead Sciences' COVID-19 treatment Veklury (remdesivir) generated some 2.2 billion U.S. dollars in revenue, a significant decrease compared to 5.6 billion in 2021.